Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Launching a clinical program of stem cell therapy for cardiovascular repair

Nature Clinical Practice Cardiovascular Medicine volume 4, pages S123–S129 (2007)Cite this article

Abstract

Since the feasibility of stem cell therapy has been recognized, enthusiasm for this therapy has grown exponentially. Nevertheless, as professionals we must realize that this enthusiasm should relate not only to our scientific interest but also to the care of our patients. Within the next decade, patients' demand for the latest therapies is likely to rise because of changes in health care systems that will broaden availability. Stem cell therapy is likely to be among these in-demand treatments, and we must be prepared for this change. In this Review we discuss the basic principles of how to launch a clinical program for stem cell therapy for cardiovascular repair. First, we look at the composition of the program team. Second, we describe the different types of stem cells available in clinical practice. Third, we present in depth the two most widely applicable delivery approaches. Finally, we discuss selection of patients and approaches and clinical and imaging methods by which to evaluate the safety and efficacy of this therapy.

Key Points

  • Preparations must be made for a rise in patients' demand for the latest therapies, including those still under investigation

  • A stem cell therapy program requires a multidisciplinary team, including cardiologists, hematologists, cardiovascular surgeons, imaging experts, basic scientists, and other professionals

  • A program's success should be assessed by surrogate endpoints, predicting changes in prognosis and quality of life, until the mechanisms of stem cell therapy are more clearly defined

  • With the information currently available, guessing the impact of stem cell therapy on survival is difficult and patients with various prognoses need to be studied

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Strauer BE et al. (2002) Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106: 1913–1918

    Article  Google Scholar 

  2. Fernandez-Aviles F et al. (2004) Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 95: 742–748

    Article  CAS  Google Scholar 

  3. Bartunek J et al. (2006) The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J 27: 1338–1340

    Article  Google Scholar 

  4. Orlic D et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410: 701–705

    Article  CAS  Google Scholar 

  5. Saha M and Ferro A (2006) Cardiac stem cell therapy: present and future. Br J Clin Pharmacol 61: 727–729

    Article  Google Scholar 

  6. Grigoropoulus NF and Mathur A (2006) Stem cells in cardiac repair. Curr Opin Pharmacol 6: 169–175

    Article  Google Scholar 

  7. Sánchez PL et al. (2006) Contemplating the bright future of stem cell therapy for cardiovascular disease. Nat Clin Pract Cardiovasc Med 3 (Suppl 1): S138–S151

    Article  Google Scholar 

  8. Herreros J et al. (2003) Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 24: 2012–2020

    Article  Google Scholar 

  9. Menasche P et al. (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41: 1078–1083

    Article  Google Scholar 

  10. Assmus B et al. (2006) Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355: 1222–1232

    Article  CAS  Google Scholar 

  11. Schachinger V et al. (2006) Intracoronary bone marrow derived progenitor cells in acute myocardial infarction. N Engl J Med 355: 1210–1221

    Article  CAS  Google Scholar 

  12. Lunde K et al. (2006) Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355: 1199–1209

    Article  CAS  Google Scholar 

  13. Schatteman GC and Awad O (2004) Hemangioblasts, angioblasts, and adult endothelial cell progenitors. Anat Rec A Discov Mol Cell Evol Biol 276: 13–21

    Article  Google Scholar 

  14. Dohmann HF et al. (2005) Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings. Circulation 112: 521–526

    Article  Google Scholar 

  15. Ozbaran M et al. (2004) Autologous peripheral stem cell transplantation in patients with congestive heart failure due to ischemic heart disease. Eur J Cardiothorac Surg 25: 342–350

    Article  Google Scholar 

  16. Kang HJ et al. (2004) Effects of intracoronary infusion of peripheral blood stem cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomised clinical trial. Lancet 363: 751–756

    Article  CAS  Google Scholar 

  17. Stamm C et al. (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361: 45–46

    Article  Google Scholar 

  18. Zipori D (2004) Mesenchymal stem cells: harnessing cell plasticity to tissue and organ repair. Blood Cells Mol Dis 33: 211–215

    Article  CAS  Google Scholar 

  19. Xu W et al. (2004) Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med 229: 623–631

    Article  CAS  Google Scholar 

  20. Valiunas V et al. (2004) Human mesenchymal stem cells make cardiac connexins and form functional gap junction. J Physiol 555: 617–626

    Article  CAS  Google Scholar 

  21. Silva GV et al. (2005) Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemic model. Circulation 111: 150–156

    Article  CAS  Google Scholar 

  22. Pittenger MF and Martin BJ (2004) Mesenchymal stem cells and their potential as cardiac therapeutics. Circulation Res 95: 9–20

    Article  CAS  Google Scholar 

  23. Menasche P et al. (2006) Routine delivery of myoblasts during coronary artery bypass surgery: why not? Nat Clin Pract Cardiovasc Med 3 (Suppl 1): S90–S93

    Article  Google Scholar 

  24. Villa A et al. (2006) Intracoronary human bone marrow stem cell transplantation in acute myocardial infarction and ventricular arrhythmias [abstract]. J Am Coll Cardiol 47: 44

    Article  Google Scholar 

  25. Fuster V et al. (2006) The utility of magnetic resonance imaging in cardiac tissue regeneration trials. Nat Clin Pract Cardiovasc Med 3 (Suppl 1): S2–S7

    Article  Google Scholar 

  26. San Roman JA and Fernandez-Aviles F (2006) The role of noninvasive imaging techniques in the assessment of stem cell therapy after acute myocardial infarction. Nat Clin Pract Cardiovasc Med 3 (Suppl 1): S38–S41

    Article  Google Scholar 

  27. Rosenzweig A (2006) Cardiac cell therapy—mixed results from mixed cells. N Engl J Med 355: 1274–1277

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Adolfo Villa, Roman Arnold and José Alberto San Román: A Villa and R Arnold are members of staff in the Imaging Unit, and JA San Román is Chief, Institute of Heart Sciences (ICICOR), Hospital Clínico Universitario, Valladolid, Spain.

Authors and Affiliations

  1. Department of Cardiology, PL Sánchez is a member of staff in the Coronary Care Unit, and F Fernández-Avilés is Professor of Cardiovascular Medicine and Chief, Hospital General Universitario Gregorio Marañón, Madrid, Spain.,

    Pedro L Sánchez & Francisco Fernández-Avilés

  2. Department of Hematology, F Sánchez-Guijo is a member of staff in, and C del Cañizo is Chief of, the Stem Cell Therapy Unit, University Hospital of Salamanca, Spain.,

    Fermín M Sánchez-Guijo & Consuelo del Cañizo

Authors
  1. Pedro L Sánchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fermín M Sánchez-Guijo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adolfo Villa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Consuelo del Cañizo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Roman Arnold
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. José Alberto San Román
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Francisco Fernández-Avilés
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francisco Fernández-Avilés.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sánchez, P., Sánchez-Guijo, F., Villa, A. et al. Launching a clinical program of stem cell therapy for cardiovascular repair. Nat Rev Cardiol 4 (Suppl 1), S123–S129 (2007). https://doi.org/10.1038/ncpcardio0767

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0767

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing